These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22809836)

  • 21. [Prenatal ultrasonic diagnosis and Down's syndrome].
    Salvesen KA; Eik-Nes SH; Tuveng JM; Sviggum O; Møller P; van der Hagen CB
    Tidsskr Nor Laegeforen; 1990 Feb; 110(6):701-4. PubMed ID: 2138828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood markers in the prenatal diagnosis of Down's syndrome: the triple test].
    Ortega-Benito JM
    Med Clin (Barc); 1995 Sep; 105(7):264-8. PubMed ID: 7475469
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Down's syndrome in a pregnant population in Finland.
    Marttala J; Yliniemi O; Gissler M; Nieminen P; Ryynanen M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):715-7. PubMed ID: 20218932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A test system of prenatal screen for Down's syndrome].
    Jiang JP; Du M; Huang XY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):109-11. PubMed ID: 16011115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How prenatal diagnosis became acceptable in France.
    Vassy C
    Trends Biotechnol; 2005 May; 23(5):246-9. PubMed ID: 15866002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arguments for offering triple test serum screening for Down's syndrome to all pregnant women].
    van der Maas PJ; Dondorp WJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):501-3. PubMed ID: 11925798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prenatal genetic diagnosis and Down's syndrome].
    Srsen S; Srsnová K
    Cesk Gynekol; 1986 May; 51(4):271-4. PubMed ID: 2941168
    [No Abstract]   [Full Text] [Related]  

  • 31. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.
    Borrell A; Borobio V; Bestwick JP; Wald NJ
    J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal screening for Down's syndrome.
    BMJ; 1991 Aug; 303(6797):312-3. PubMed ID: 1832325
    [No Abstract]   [Full Text] [Related]  

  • 34. [Genetic counseling and prenatal diagnosis in Down's syndrome].
    Papp Z
    Orv Hetil; 1974 May; 115(19):1103-6. PubMed ID: 4274931
    [No Abstract]   [Full Text] [Related]  

  • 35. [Down's syndrome. Genetic counseling and prenatal diagnosis].
    Fuhrmann W
    Dtsch Med Wochenschr; 1979 Jul; 104(30):1055-8. PubMed ID: 157268
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive prenatal testing: clinical utility and ethical concerns about recent advances.
    Thomas J; Harraway J; Kirchhoffer D
    Med J Aust; 2021 Mar; 214(4):168-170.e1. PubMed ID: 33423294
    [No Abstract]   [Full Text] [Related]  

  • 38. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulating preimplantation genetic diagnosis: the case of Down's syndrome.
    Krahn TM
    Med Law Rev; 2011; 19(2):157-91. PubMed ID: 21531756
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethical and legal issues regarding selective abortion of fetuses with Down syndrome.
    Glover NM; Glover SJ
    Ment Retard; 1996 Aug; 34(4):207-14. PubMed ID: 8828339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.